Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Market Cap	8.13B
Revenue (ttm)	2.99B
Net Income (ttm)	191.75M
Shares Out	343.93M
EPS (ttm)	0.55
PE Ratio	42.73
Forward PE	31.31
Dividend	0.05 (0.21%)
Ex-Dividend Date	n/a

Volume	1,663,243
Average Volume	1,817,155
Open	24.01
Previous Close	23.64
Day's Range	23.40 - 24.01
52-Week Range	15.52 - 31.20
Beta	0.60
RSI	40.77
Earnings Date	Apr 17, 2026

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 4,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300702

Financial Performance

In 2024, SHE:300702's revenue was 2.63 billion, an increase of 4.10% compared to the previous year's 2.53 billion. Earnings were 55.94 million, an increase of 104.45%.